Tag: NDA

Business

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) Up 6.93% After FDA Accepts to Review its ZIMHI NDA

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) gained 6.93% following the announcement that the FDA had accepted to review its resubmitted New Drug Application for ZIMHI™. ZIMHI is a higher naloxone injection product candidate under development by the company for opioid overdose treatment. It lost 5.56% in the last trading session. The […]